ALLMedicine™ Type 2 Diabetes Center
Research & Reviews 114,203 results
https://doi.org/10.1002/oby.23093
Obesity (Silver Spring, Md.); Katsogiannos P, Kamble PG et. al.
Feb 24th, 2021 - This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux-en-Y gastric bypass (RYGB) with healthy controls. A total of 34 patients (21 with T2D) wi...
https://doi.org/10.1152/ajpregu.00318.2020
American Journal of Physiology. Regulatory, Integrative A... Gildea N, McDermott A et. al.
Feb 24th, 2021 - In the present study we assessed the time course of adaptations in peak oxygen uptake (V̇O2peak) and muscle fractional oxygen (O2) extraction (using near-infrared spectroscopy) following 12 weeks of low-volume high-intensity interval training (HII...
https://doi.org/10.2174/1573399817666210223114010
Current Diabetes Reviews; Kumar A, Hejmady DI et. al.
Feb 24th, 2021 - To estimate the adherence to treatment among type 2 diabetic patients. Treatment adherence is a complex process which is controlled by multiple factors. Lack of treatment adherence is common with patients who suffer from type 2 diabetes and is bec...
https://doi.org/10.1186/s12882-021-02271-8 10.1016/S0140-6736(14)61601-9 10.1056/NEJMoa0806359 10.1681/ASN.2012070718 10.1159/000168653 10.1016/j.bbrc.2010.10.012 10.1007/s11010-019-03535-6 10.1016/S0140-6736(78)91505-2 10.1016/S0140-6736(07)60527-3 10.1161/01.CIR.102.22.2677 10.1172/JCI13210 10.1016/j.atherosclerosis.2013.09.023 10.1253/circj.CJ-11-0941 10.1161/CIRCULATIONAHA.114.011590 10.1136/gutjnl-2017-313778 10.2337/dc07-0931 10.1161/CIR.0000000000000510 10.1186/1475-2840-12-21 10.1007/s10157-013-0879-4 10.2337/dc10-1303 10.1017/S1368980011000504 10.1210/jcem-66-4-678 10.1007/BF00505658 10.1016/S0090-6980(98)00066-5 10.1016/j.yexcr.2007.03.036 10.1159/000183217 10.1161/CIRCHEARTFAILURE.116.003291 10.18632/oncotarget.25005 10.1016/j.cmet.2017.01.004 10.2337/diabetes.51.10.3090 10.1681/ASN.2014040350
BMC Nephrology; Okamura T, Nakajima H et. al.
Feb 24th, 2021 - Diabetic nephropathy, a major complication of diabetes, is the primary risk factor for dialysis, cardiovascular diseases, and mortality. Dietary fatty acids (FAs) have been revealed to be related with cardiovascular diseases in the general populat...
https://doi.org/10.1186/s13148-021-01027-3 10.1007/s00125-015-3773-7 10.1093/hmg/ddv232 10.1016/S0140-6736(11)60614-4 10.1210/er.2015-1137 10.1007/s00592-015-0741-0 10.2337/diacare.21.3.C3 10.2337/db16-1253 10.1038/s41588-018-0241-6 10.1038/nrg3000 10.1038/nrg3405 10.1007/978-94-007-2495-2 10.1093/hmg/ddv493 10.3389/fendo.2018.00744 10.1186/s13059-016-0926-z 10.1186/1471-2164-15-860 10.1038/s41467-019-12228-z 10.1080/15592294.2016.1178418 10.1016/j.molmet.2018.01.022 10.1186/s13148-016-0177-6 10.1016/S2213-8587(15)00127-8 10.2337/db18-0290 10.1093/ije/dyy171 10.1007/s00125-017-4497-7 10.1093/bioinformatics/btv560 10.1093/bioinformatics/btv612 10.1038/ng.3721 10.1038/ng.521 10.1038/ng.520 10.1093/hmg/ddv161 10.2337/db13-1100 10.1161/CIRCGENETICS.114.000804 10.1371/journal.pone.0152314 10.2337/dc19-1828 10.2337/dc12-0082 10.1038/nature20784 10.1161/CIRCULATIONAHA.114.009158 10.1093/hmg/ddt430 10.1194/jlr.M048504 10.1016/j.numecd.2016.11.004 10.1371/journal.pone.0145789 10.1161/ATVBAHA.117.310340 10.1016/j.celrep.2018.05.035 10.3389/fphar.2018.00207 10.1161/CIRCGENETICS.116.001506 10.1080/15592294.2016.1278097 10.1016/B978-0-12-814259-2.00012-1 10.1093/ije/dyz119 10.2337/db15-0996 10.1093/hmg/ddx164 10.1093/ije/dys066 10.1093/ije/dys064 10.1186/1471-2318-7-28 10.1093/ije/dyr197 10.1093/ije/dyy022 10.1007/s10654-017-0321-4 10.1007/s10654-020-00640-5 10.1055/s-2005-858235 10.1186/1471-2105-13-86 10.1093/bioinformatics/bts034 10.1080/01621459.1986.10478363 10.1186/s13148-017-0414-7 10.1186/s13073-020-0716-9 10.3390/nu11112804 10.1093/bioinformatics/bty362 10.1093/bioinformatics/btq340 10.18637/jss.v036.i03 10.1093/bioinformatics/bts545 10.1186/1756-8935-6-26 10.1038/ng.2897 10.2337/db10-0502
Clinical Epigenetics; Juvinao-Quintero DL, Marioni RE et. al.
Feb 24th, 2021 - Type 2 diabetes (T2D) is a heterogeneous disease with well-known genetic and environmental risk factors contributing to its prevalence. Epigenetic mechanisms related to changes in DNA methylation (DNAm), may also contribute to T2D risk, but larger...
Guidelines 401 results
https://www.nih.gov/news-events/nih-research-matters/drug-activates-brown-fat-improves-glucose-metabolism-healthy-women
National Institutes of Health (NIH)
Feb 3rd, 2021 - The majority of adults in the U.S. carry too much fat in their bodies and are now considered overweight or obese. The last several decades have also seen a spike in related diseases of metabolism, such as type 2 diabetes.
https://www.nih.gov/news-events/nih-research-matters/brown-fat-associated-less-heart-metabolic-disease
National Institutes of Health (NIH)
Feb 1st, 2021 - Too much white fat, a characteristic of obesity, has been shown to increase the risk of type 2 diabetes, high blood pressure, and other diseases. A less common type of fat, called brown fat, uses blood sugar and fat molecules to create heat and he...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785422/
Obesity Medicine; Pang J, Liu M et. al.
Jan 5th, 2021 - COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic since WHO made the statement on March 11, 2020. The infection is causing a high mortality in old people, especially those with obesity, type 2 di...
https://pubmed.ncbi.nlm.nih.gov/33198768/
BMC Medicine; Escala-Garcia M
Nov 16th, 2020 - Observational studies have investigated the association of risk factors with breast cancer prognosis. However, the results have been conflicting and it has been challenging to establish causality due to potential residual confounding. Using a Mend...
https://www.rheumatologyadvisor.com/home/conference-highlights/acr-convergence-2020/comparative-performance-of-sglt2-inhibitors-in-reducing-gout-in-t2d/
Nov 8th, 2020 - Among patients with type 2 diabetes (T2D), sodium-glucose cotransporter-2 (SGLT2) inhibitors dapagliflozin and empagliflozin vs canagliflozin show greater benefit in reducing gout, according to research results presented at the American College of...
Drugs 2,543 results see all →
Clinicaltrials.gov 123,621 results
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=86acdd9e-8637-43e4-8bf7-b3a123b871b8
Aug 12th, 2021 - Glimepiride tablets USP are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14.1) ]. Limitations of Use Glimepiride tablets USP should not be used for the trea...
https://doi.org/10.1002/oby.23093
Obesity (Silver Spring, Md.); Katsogiannos P, Kamble PG et. al.
Feb 24th, 2021 - This study aimed to compare cytokine and adipokine levels in patients with obesity with and without type 2 diabetes (T2D) at baseline and 6 months after Roux-en-Y gastric bypass (RYGB) with healthy controls. A total of 34 patients (21 with T2D) wi...
https://doi.org/10.1152/ajpregu.00318.2020
American Journal of Physiology. Regulatory, Integrative A... Gildea N, McDermott A et. al.
Feb 24th, 2021 - In the present study we assessed the time course of adaptations in peak oxygen uptake (V̇O2peak) and muscle fractional oxygen (O2) extraction (using near-infrared spectroscopy) following 12 weeks of low-volume high-intensity interval training (HII...
https://doi.org/10.2174/1573399817666210223114010
Current Diabetes Reviews; Kumar A, Hejmady DI et. al.
Feb 24th, 2021 - To estimate the adherence to treatment among type 2 diabetic patients. Treatment adherence is a complex process which is controlled by multiple factors. Lack of treatment adherence is common with patients who suffer from type 2 diabetes and is bec...
https://doi.org/10.1186/s12882-021-02271-8 10.1016/S0140-6736(14)61601-9 10.1056/NEJMoa0806359 10.1681/ASN.2012070718 10.1159/000168653 10.1016/j.bbrc.2010.10.012 10.1007/s11010-019-03535-6 10.1016/S0140-6736(78)91505-2 10.1016/S0140-6736(07)60527-3 10.1161/01.CIR.102.22.2677 10.1172/JCI13210 10.1016/j.atherosclerosis.2013.09.023 10.1253/circj.CJ-11-0941 10.1161/CIRCULATIONAHA.114.011590 10.1136/gutjnl-2017-313778 10.2337/dc07-0931 10.1161/CIR.0000000000000510 10.1186/1475-2840-12-21 10.1007/s10157-013-0879-4 10.2337/dc10-1303 10.1017/S1368980011000504 10.1210/jcem-66-4-678 10.1007/BF00505658 10.1016/S0090-6980(98)00066-5 10.1016/j.yexcr.2007.03.036 10.1159/000183217 10.1161/CIRCHEARTFAILURE.116.003291 10.18632/oncotarget.25005 10.1016/j.cmet.2017.01.004 10.2337/diabetes.51.10.3090 10.1681/ASN.2014040350
BMC Nephrology; Okamura T, Nakajima H et. al.
Feb 24th, 2021 - Diabetic nephropathy, a major complication of diabetes, is the primary risk factor for dialysis, cardiovascular diseases, and mortality. Dietary fatty acids (FAs) have been revealed to be related with cardiovascular diseases in the general populat...
News 9,559 results
https://www.medscape.com/viewarticle/946380
Feb 23rd, 2021 - Goldenseal, a natural botanical product, may interfere with intestinal absorption of metformin, potentially compromising blood glucose control in patients with type 2 diabetes, according to investigators. The study, which tested for interactions b...
https://www.medscape.com/viewarticle/946279
Feb 22nd, 2021 - Takeaway Type 2 diabetes (T2D) is associated with pulmonary function impairment, independent of sex, smoking status, or worldwide location.
https://www.medscape.com/viewarticle/946022
Feb 18th, 2021 - Takeaway This study found a reduced risk of rheumatoid arthritis (RA) that was potentially attributable to the use of statin in patients with type 2 diabetes (T2D).
https://www.medscape.com/viewarticle/945829
Feb 14th, 2021 - People with type 2 diabetes as young as 40 years of age face a disproportionately increased risk of dying from COVID-19 infection, indicates a UK analysis of three large-scale datasets that shines a light on the need to prioritize vaccinations in ...
https://www.medscape.com/viewarticle/945645
Feb 10th, 2021 - Patients with type 2 diabetes and the highest level of variability in their A1c levels over 2 years had significantly more first cardiovascular disease (CVD) events than similar patients with less A1c variability, in a retrospective analysis of mo...
